Citation:Roobol MJ, Carlsson S, Hugosson J 2011
From National Cancer Control Policy
Roobol MJ, Carlsson S, Hugosson J. Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductions. Evid Based Med 2011 Feb;16(1):20-1 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21228057.
Critical appraisals